Rhythm Pharmaceuticals

RYTMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.961 B

$115.63 +3.15%

Close of 7 Aug 2026

Revenue

$189.8M

#2311 by revenue

Earnings

-$196.5K

Loss-making

Shares outstanding

68,852,082

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#43AlkermesALKS$8.25B
#44LiquidiaLQDA$8.02B
#45Rhythm PharmaceuticalsRYTM$7.96B
#46Tg TherapeuticsTGTX$7.62B
#47Cogent BiosciencesCOGT$7.24B

Where these numbers come from

Share counts and financials for Rhythm Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.